Program GoalsPleural disease is a common but frequently misunderstood clinical entity within the field of pulmonary disease. While up to 30% of individuals assessed may have pleural effusions, the specific diagnostic and therapeutic modalities undertaken have significant downstream implications for the diagnostic yield of studies, potential complication profile, and in the setting of therapeutic procedures, the extent to which these can either help to facilitate overall treatment or to reduce symptom burden in the case of palliative-type procedures such as tunneled pleural catheters or chemical pleurodesis for malignant pleural effusions. While pleural procedures are commonly performed by pulmonologists, thoracic surgeons, interventional radiologists, and in some centers, hospitalists, the specific indications for these procedures are frequently misunderstood. As such, diagnostic thoracenteses are frequently ordered with incomplete studies, thoracenteses are performed where chest tubes should be placed, and inappropriate type of chest tube is inserted, or patients are subjected to multiple procedures while a single definitive procedure could be performed. Our goal is to present these details and distinctions with a target audience of general internists, hospitalists, and advanced practice providers. Target AudiencePulmonologists, Critical Care Specialists, Internal Medicine and Primary Care Physicians, Physician Assistants, Advanced Practice Nurses, and Nurse Practitioners. Learning ObjectivesAfter the conclusion of this activity, participants should be able to:
FacultyDavid R. Manoff, M.D. Educational Activity AgendaEducational Presentation (59 minutes) Release and Expiration DatesRelease Date: March 1, 2024 Disclosure PolicyIt is the policy of the Lewis Katz School of Medicine at Temple University, The Albert J. Finestone, M.D., Office for Continuing Medical Education that anyone in a position to control the content of a certified educational activity must disclose any financial relationships with ineligible companies within the prior 24 months. The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” Speakers must also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. The Lewis Katz School of Medicine at Temple University has policies in place that will identify and mitigate all conflicts of interest prior to the educational activity. Detailed disclosure will be communicated to learners prior to the activity. Faculty DisclosuresThe faculty disclosed the following financial relationships with ineligible companies related to the content of this educational activity. David R. Manoff, M.D. None of the faculty for this educational activity have relevant financial relationships to disclose with ineligible companies. Course Directors, Planners, Reviewers, and Managers/CME Staff DisclosuresThe course directors, planners, reviewers, and managers/CME staff disclosed the following financial relationships with ineligible companies related to the content of this educational activity: David R. Manoff M.D. (Planner and Faculty) Andrew J. Gangemi, M.D. (Reviewer) Arnold I. Meyer, Ed.D, FACEHP (Planner and CME Staff) *None of the course directors, planners, reviewers, and managers/CME staff for this educational activity have relevant financial relationships to disclose with ineligible companies. Accreditation StatementLewis Katz School of Medicine at Temple University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians. Certification StatementLewis Katz School of Medicine at Temple University designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. How to Obtain CME CreditAttendees are expected to view all presentations before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credit(s)™. To receive credit, the course must be completed between March 1, 2024 - March 1, 2026. Participation in this activity should be completed in approximately 1.0 hour(s). Please follow these steps in order to receive CME/CE credit for viewing the webcast:
After successfully completing the online test and/or evaluation, your application will be immediately processed, and you will be given the opportunity to download a personalized CME/CE certificate for participation in this activity. Should you have any CME questions regarding this activity, please contact: The Albert J. Finestone, MD Office for Continuing Medical Education Commercial Support StatementNo commercial support has been provided for this activity. System RequirementsTo view this educational activity you, will need a web browser with JavaScript and either Flash or HTML5 enabled. Nearly all modern web browsers will work. If you have special accommodations that we can address to make your participation more meaningful and enjoyable, please contact our office at (215) 707-4787 or cme@temple.edu. CopyrightCopyright © 2024. Temple University. Philadelphia, PA. All rights reserved. | ||
Web interface provided by Dane Garvin Ltd.
|